Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 21, 2016 - Issue 6
Submit an article Journal homepage
333
Views
10
CrossRef citations to date
0
Altmetric
Original Research Article

Emergency contraception: a survey of 1773 women

Carlo BastianelliDepartment of Gynaecology–Obstetrics and Urology, Sapienza University of Rome, Rome, Italy;
,
Elena RosatoDepartment of Gynaecology–Obstetrics and Urology, Sapienza University of Rome, Rome, Italy;
,
Manuela FarrisDepartment of Gynaecology–Obstetrics and Urology, Sapienza University of Rome, Rome, Italy; ;AIED Italian Association for Demographic Education, Rome, ItalyCorrespondence[email protected]
&
Giuseppe BenagianoDepartment of Gynaecology–Obstetrics and Urology, Sapienza University of Rome, Rome, Italy;
Pages 455-461 | Received 11 Jul 2016, Accepted 14 Sep 2016, Published online: 29 Sep 2016

References

  • Kalhlenborn C, Stanford JB, Larimore WL. Postfertilization effect of hormonal emergency contraception. Ann Pharmacother. 2002;36:465–470.
  • Comitato Nazionale per la Bioetica. Nota sulla contraccezione di emergenza [Internet]. [cited 2016 May 24]. Available from: www.palazzochigi.it/bioetica/mozioni/index.html.
  • Bastianelli C, Farris M, Benagiano G. Reasons for requesting emergency contraception: a survey of 506 Italian women. Eur J Contracept Reprod Health Care. 2005;10:157–163.
  • AIFA. Nota informativa importante concordata con le autorità regolatorie europee e l’Agenzia Italiana del Farmaco (AIFA) su ellaOne (ulipristal acetato) [Internet]. [cited 2016 May 24]. Available from: www.agenziafarmaco.gov.it/sites/default/files/nota_informativa_importante_ellaone.pdf.
  • AIFA, Agenzia Italiana del Farmaco. Gazzetta Ufficiale della Repubblica Italiana n. 105 del 8 maggio 2015. Determina 21 Aprile 2015. Modifica alla determina 8 novembre 2011, n. 2703, recante: Regime di rimborsabilità e prezzo di vendita del medicinale per uso umano Ellaone (ulipristal) [Internet]. [cited 2016 May 24]. Available from: www.gazzettaufficiale.biz/atti/2015/20150105/15A03360.htm.
  • European Medicines Agency. EMA recommends availability of ellaOne emergency contraceptive without prescription [Internet]. 21 November 2014. EMA/710568/2014. [cited 2016 May 24]. Available from: www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/11/WC500177649.pdf.
  • European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Assessment report. 4 December 2014, rev 1. EMA/73099/2015 [Internet]. [cited 2016 May 24]. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/001027/WC500181904.pdf.
  • HRA Pharma Italy. Data on file by the pharmaceutical company; 2016.
  • Centre Regional d’Information et de Prévention du SIDA (CRIPS). Données sur la contraception, la contraception d’urgence et l’IVG en France [Internet]. Dossier de synthèse documentaire et bibliographique, mai 2014. [cited 2016 May 24]. Available from: http://paca.lecrips.net/spip.php?article249.
  • Fontes E, Guerreiro J, Costa T, et al. Pattern of use of emergency oral contraception among Portuguese women. Pharm World Sci. 2010;32:496–502.
  • Hansen CC, Svare EI, Petersen RH, et al. Who are the users of emergency contraception? Ugeskr Laeger. 2002;164:5003–5005.
  • Loughrey F, Matthews A, Bedford D, et al. Characteristics of women seeking emergency contraception in general practice. Ir Med J. 2006;99:50–52.
  • Stirnemann JJ, Samson A, Bernard J-P, et al. Day-specific probabilities of conception in fertile cycles resulting in spontaneous pregnancies. Hum Reprod. 2013;2:1110–1116.
  • Moreau C, Trussell J, Michelot F, et al. The effect of access to emergency contraceptive pills on women's use of highly effective contraceptives: results from a French national cohort study. Am J Public Health. 2009;99:441–442.
  • Samartzis EP, Merki-Feld GS, Seifert B, et al. Six years after deregulation of emergency contraception in Switzerland: has free access induced changes in the profile of clients attending an emergency pharmacy in Zürich?. Eur J Contracept Reprod Health Care. 2012;17:197–204.
  • Gainer E, Blum J, Toverud EL, et al. Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. Contraception. 2003;68:117–124.
  • Haute Autorité de Santé (HAS). Ellaone (ulipristal), modulateur des récepteurs de la progestérone [Internet]. Progrès thérapeutique mineur par rapport à Norlevo dans la contraception d’urgence 2010. [cited 2016 May 24]. Available from: www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/synthese_davis_ellaone_-_ct-7137.pdf.
  • Jamin C. Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse. Gynécol Obstét Fertil. 2015;43:242–247.
  • Brache V, Cochon L, Deniaud M, et al. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception. 2013;88:611–618.
  • Rosato E, Farris M, Bastianelli C. Mechanism of action of ulipristal acetate for emergency contraception: a systematic review. Front Pharmacol. 2016;6:315.
  • Tafuri S, Martinelli D, Germinario C, et al. A survey of opinions on emergency contraception in young women in southern Italy. Eur J Contracept Reprod Health Care. 2012;17:164–169.
  • Falah-Hassani K, Kosunen E, Shiri R, et al. Emergency contraception among Finnish adolescents: awareness, use and the effect of nonprescription status. BMC Public Health. 2007;7:201.
  • Lete I, Cabero L, Alvarez D, et al. Observational study on the use of emergency contraception in Spain: results of a national survey. Eur J Contracept Reprod Health Care. 2003;8:203–209.
  • Nappi RE, Lobo Abascal P, Mansour D, Emergency Contraception Study Group, et al. Use of and attitudes towards emergency contraception: a survey of women in five European countries. Eur J Contracept Reprod Health Care. 2014;19:93–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.